Compositions and methods for immunooncology
US-2024417722-A1 · Dec 19, 2024 · US
This page is not indexed by search engines while we improve data quality.
Intellia Therapeutics Inc — Cross-Sectional Technologies
Intellia Therapeutics Inc holds 3 patents in Cross-Sectional Technologies, with representative filings summarized below.
| Metric | Value |
|---|---|
| Company | Intellia Therapeutics Inc |
| Technology | Cross-Sectional Technologies |
| Patents in slice | 3 |
| Recent patents in slice | 2 |
| First year | 2018 |
| Last year | 2024 |
Representative patents
Notable publications linking Intellia Therapeutics Inc to Cross-Sectional Technologies.
Compositions and methods for immunooncology
US-12037583-B2 · Jul 16, 2024 · US
Compositions and methods for immunooncology
US-2018362975-A1 · Dec 20, 2018 · US
Recent filings
Latest patents from Intellia Therapeutics Inc in Cross-Sectional Technologies.
Compositions and methods for immunooncology
US-2024417722-A1 · Dec 19, 2024 · US
Compositions and methods for immunooncology
US-12037583-B2 · Jul 16, 2024 · US
Compositions and methods for immunooncology
US-2018362975-A1 · Dec 20, 2018 · US
Related pages
Navigate to parent entity pages.